A pharma miscellany.
Jan 1, 2009
By:Stephen E. Gerard
How hopeful are execs about the future of their own companies and the industry in general?
 |
The other half of an HIV mystery is solved
Nov 1, 2008
HIV infection unzips its genes
|
A head-to-head analysis of the two brands
Oct 1, 2008
By:Walter Armstrong
A head-to-head comparison of the Drug Vote '08
|
Sep 1, 2008
By:Walter Armstrong
Young & Partners crunches pharma's filings for, the first half of '08. The results? Ask the Japanese
|
Aug 1, 2008
By:Patrick Clinton
There's a cure for everything, as long as the patient is a mouse
|
No, it's not as glamorous as its double-helixed offspring. But recent revelations about RNA turn even cold-eyed scientists into lyrical romantics
Jul 1, 2008
By:Walter Armstrong
No, it's not as glamorous as its double-helixed offspring. But recent revelations about RNA turn even cold-eyed scientists into lyrical romantics
|
May 1, 2008
By:Walter Armstrong
A plunging currency and other economic turmoil shouldn't phase pharma, right? Yes and no
|
Apr 1, 2008
By:Walter Armstrong
When it comes to developing novel therapies from the animal kingdom, it's mostly a game of pick your poison
|
Americans take top spots in disease prevalence
Mar 1, 2008
By:Humphrey Taylor
Americans take top spots in disease prevalence
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?
Don't miss this Podcast series commemorating the 20th anniversary of HBA's Woman of the Year Award with interviews spanning two decades of change makers.
If you're searching for a new business location, attend the Business Facilities LiveXchange event and learn from location experts, meet with economic developers, and network with peers, all at no cost to you!